A biodegradable suction patch for sustainable transbuccal peptide delivery., PMID:40513668
Investigation of factors associated with osteoporosis using metabolome analysis., PMID:40510386
Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center., PMID:40509705
Conservative Treatment with Teriparatide Versus Vertebroplasty for Acute Osteoporotic Vertebral Compression Fractures: A Meta-Analysis., PMID:40507727
Prolonged hypercalcemia induced by teriparatide: a case report and literature review., PMID:40500389
Investigation of clinical outcomes in conservative management of hook fractures: Commentary on recent findings., PMID:40496257
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis., PMID:40469971
Application of teriparatide in CKD-related osteoporosis: efficacy and safety considerations., PMID:40465117
Novel Aptamers Targeting Sclerostin Loop3 Improve Skeletal and Muscle Properties Without Adverse Cardiovascular Effects in Orchiectomized Mice., PMID:40464222
A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation., PMID:40461584
Treatment of Osteoporosis in Patients with Chronic Kidney Disease., PMID:40457078
Methodological concerns, implausibly early fracture reduction, and potential outcome misclassification: Comment on "Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design"., PMID:40456504
Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk., PMID:40445411
Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data., PMID:40426310
Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05., PMID:40425867
3D printed Gel/PTH@PAHA scaffolds with both enhanced osteogenesis and mechanical properties for repair of large bone defects., PMID:40416645
Compliance With Parathyroid Hormone Analog Medications at a Single Osteoporosis Treatment Center., PMID:40416275
Teriparatide as an adjuvant therapy in the management of advanced-stage medication-related osteonecrosis of the jaw., PMID:40399210
Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy., PMID:40385888
Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design., PMID:40381877
Agents to treat osteoporosis in chronic kidney disease., PMID:40377654
CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro., PMID:40376984
Sequential Cranial and Overlooked Cervical Spine Injuries Due to Head Trauma: A Billiard-Like Mechanism., PMID:40376325
Impact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications., PMID:40364278
Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis., PMID:40357344
Assessing the Efficacy of Romosozumab in Postmenopausal Osteoporosis: An Updated Systematic Review and Meta-analysis., PMID:40323656
National guidelines for diagnosis and treatment of osteoporosis in Slovakia., PMID:40319419
Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis., PMID:40309441
Male Osteoporosis: A Comprehensive Review of Treatment Approaches in Modern Pharmacotherapy and Traditional Chinese Medicine Interventions., PMID:40304326
Management Concepts of Bisphosphonate-Related Atypical Femoral Fractures., PMID:40283688
Anti-osteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis., PMID:40280495
Hypophosphatasia: Clinical Clues and Management Considerations., PMID:40255721
Palopegteriparatide (Yorvipath) for hypoparathyroidism., PMID:40254729
[Sequential drug treatments for osteoporosis]., PMID:40241552
[Clinical efficacy of osteoporosis treatments]., PMID:40241551
Treatment period and changes in bone markers according to the application of teriparatide in treating medication-related osteonecrosis of the jaw., PMID:40217244
Optimizing bone health for the prevention of revision adult spinal deformity surgery: a break-even analysis., PMID:40214908
Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide., PMID:40214193
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database., PMID:40213702
Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis., PMID:40205203
Challenges Posed by Osteoporosis in Arthroscopy and Sports Injury Management., PMID:40201910
An oral robotic pill reliably and safely delivers teriparatide with high bioavailability in healthy volunteers: A phase 1 study., PMID:40194767
Preoperative teriparatide intervention is cost-effective for osteoporotic patients undergoing lumbar fusion: a break-even cost analysis., PMID:40194707
A Random Study of Comparing the Efficacy of Antiosteoporosis Therapy at Different Time Points Combined With Oblique Lateral Interbody Fusion in the Treatment of Lumbar Degenerative Disease Patients Complicated With Osteoporosis., PMID:40192718
Effects of asfotase alfa on fracture healing of adult patient with hypophosphatasia and literature review., PMID:40189581
Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects., PMID:40181849
An update on the pharmacotherapy of osteoporosis., PMID:40178951
Teriparatide mitigates oxidative stress following spinal cord injury and enhances neurological recovery via the Nrf2/HO-1 signaling pathway., PMID:40176894
Foot Drop, Wrist Drop, and Digital Ischemia As Initial Manifestations in Sjögren's Disease., PMID:40151716
Teriparatide-induced Sever Persistent Hypercalcemia in an Osteoporotic Patient: A Case Report and Literature Review., PMID:40151587
For research use only. Not for human or drug use.
